ClinConnect ClinConnect Logo
Search / Trial NCT06428461

Evaluation of Supraclavicular Brachial Plexus Blocks At Various Volumes: Impact on Optic Nerve Sheath Diameter

Launched by PAMUKKALE UNIVERSITY · May 22, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Supraclavicular Brachial Plexus Block Intracranial Pressure Optic Nerve Sheath Diameter

ClinConnect Summary

This clinical trial is studying a type of anesthesia called supraclavicular brachial plexus blocks, which is used to numb the arm and shoulder area during surgery. Researchers want to find out how effective this method is at different volumes, how well it works for pain relief after surgery, and if it causes any side effects. They will also use ultrasound, a special imaging technique, to check the size of the optic nerve sheath, which can help understand changes in pressure inside the brain related to this anesthesia technique.

To participate in the trial, you need to be between 18 and 50 years old and scheduled for surgery on your finger, wrist, or elbow. You should be generally healthy, classified as ASA I or II, which means you're not seriously ill. If you agree to join, you'll be informed about the anesthesia method and the tests involved and will need to sign a consent form. It's important to know that certain health conditions, like severe heart problems or recent heart attacks, might exclude you from participating. If you decide to take part, you can expect to receive detailed information about the procedures and what to expect during the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged between 18 and 50, of both genders, with planned surgery on the finger, wrist, elbow joint, and distal region, and classified as ASA I-II, will be included in the study. In this study, patients will be informed about the anesthesia method and the tests to be conducted, and those who consent will be asked to sign an informed consent form as voluntary participants.
  • Exclusion Criteria:
  • Patients who do not accept the procedures and tests
  • Those with diseases that may cause increased intracranial pressure
  • Patients with severe heart failure
  • Patients with second or third degree atrioventricular block
  • Patients with unstable angina history
  • Patients with COPD and chronic asthma
  • Patients with a history of myocardial infarction (MI) within the last 6 weeks
  • Patients with a heart rate below 50 beats/min
  • Patients with systolic blood pressure below 90 mmHg
  • Patients with liver failure
  • Patients with kidney failure
  • Patients for whom supraclavicular block anatomically cannot be performed
  • Those with neurological or psychological diseases that make it difficult to assess the tests
  • Patients allergic to any of the study drugs
  • Pregnant women

About Pamukkale University

Pamukkale University is a renowned academic institution located in Denizli, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the broader scientific community. With a commitment to ethical standards and regulatory compliance, Pamukkale University fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring the rigorous execution of clinical trials that address critical health challenges. Through its research initiatives, the university aims to enhance the understanding of various medical conditions and support the development of effective therapies.

Locations

Denizli, Pamukkale, Turkey

Patients applied

0 patients applied

Trial Officials

Rıza Hakan Erbay

Study Director

Pamukkale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported